EOLS
Evolus Inc.
$6.63
-$0.11(-1.63%)
62
Overall
40
Value
91
Tech
55
Quality
Market Cap
$436.62M
Volume
1.10M
52W Range
$3.86 - $10.20
Target Price
$15.60
Company Overview
| Mkt Cap | $436.62M | Price | $6.63 |
| Volume | 1.10M | Change | -1.63% |
| P/E Ratio | -8.5 | Open | $6.77 |
| Revenue | $297.2M | Prev Close | $6.74 |
| Net Income | $-51.6M | 52W Range | $3.86 - $10.20 |
| Div Yield | N/A | Target | $15.60 |
| Overall | 62 | Value | 40 |
| Quality | 55 | Technical | 91 |
No chart data available
About Evolus Inc.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest News
Evolus Shareholders Elect Directors and Ratify Key Proposals
TipRanks Auto-Generated Newsdesk•8 days ago
Evolus (EOLS) Receives a Buy from Mizuho Securities
TipRanks Auto-Generated Intelligence Newsdesk•12 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EOLS | $6.63 | -1.6% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |